
Thomas Brown
Examiner (ID: 11072)
| Most Active Art Unit | 2601 |
| Art Unit(s) | 2786, 2899, 2742, 2787, 2306, 2601, 2604, 2305, 2857 |
| Total Applications | 1242 |
| Issued Applications | 1062 |
| Pending Applications | 29 |
| Abandoned Applications | 151 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8417880
[patent_doc_number] => 20120245380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => 'Inhibition of Ornithine Aminotransferase for the Treatment of Proliferative Disorders'
[patent_app_type] => utility
[patent_app_number] => 13/484392
[patent_app_country] => US
[patent_app_date] => 2012-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10982
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13484392
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/484392 | Inhibition of ornithine aminotransferase for the treatment of proliferative disorders | May 30, 2012 | Issued |
Array
(
[id] => 10830801
[patent_doc_number] => 08858963
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-10-14
[patent_title] => 'Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia'
[patent_app_type] => utility
[patent_app_number] => 13/473578
[patent_app_country] => US
[patent_app_date] => 2012-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 54695
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13473578
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/473578 | Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia | May 15, 2012 | Issued |
Array
(
[id] => 11303643
[patent_doc_number] => 09511024
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-06
[patent_title] => 'Amino lipids, their synthesis and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/124468
[patent_app_country] => US
[patent_app_date] => 2012-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 6883
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124468
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/124468 | Amino lipids, their synthesis and uses thereof | May 14, 2012 | Issued |
Array
(
[id] => 8549528
[patent_doc_number] => 08324410
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-04
[patent_title] => 'Modified drugs for use in liposomal nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 13/467021
[patent_app_country] => US
[patent_app_date] => 2012-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 28275
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13467021
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/467021 | Modified drugs for use in liposomal nanoparticles | May 7, 2012 | Issued |
Array
(
[id] => 8370214
[patent_doc_number] => 20120219606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'Oral Care Compositions Comprising Spherical Fused Silica'
[patent_app_type] => utility
[patent_app_number] => 13/463149
[patent_app_country] => US
[patent_app_date] => 2012-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 24935
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13463149
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/463149 | Oral care compositions comprising spherical fused silica | May 2, 2012 | Issued |
Array
(
[id] => 10026672
[patent_doc_number] => 09068565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-30
[patent_title] => 'Container and method for storing a pharmaceutical agent'
[patent_app_type] => utility
[patent_app_number] => 13/463509
[patent_app_country] => US
[patent_app_date] => 2012-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 4288
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13463509
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/463509 | Container and method for storing a pharmaceutical agent | May 2, 2012 | Issued |
Array
(
[id] => 8784316
[patent_doc_number] => 08431155
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-04-30
[patent_title] => 'Bromocriptine formulations'
[patent_app_type] => utility
[patent_app_number] => 13/460452
[patent_app_country] => US
[patent_app_date] => 2012-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 12319
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13460452
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/460452 | Bromocriptine formulations | Apr 29, 2012 | Issued |
Array
(
[id] => 8476611
[patent_doc_number] => 20120276018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/458072
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26048
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13458072
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/458072 | Alkaloid ester and carbamate derivatives and medicinal compositions thereof | Apr 26, 2012 | Issued |
| 13/454532 | SOLID ORAL DOSAGE FORMS OF VALSARTAN | Apr 23, 2012 | Abandoned |
Array
(
[id] => 9839650
[patent_doc_number] => 20150031732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'FEBUXOSTAT SOLID DISPERSION'
[patent_app_type] => utility
[patent_app_number] => 14/111332
[patent_app_country] => US
[patent_app_date] => 2012-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1673
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111332
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/111332 | FEBUXOSTAT SOLID DISPERSION | Apr 15, 2012 | Abandoned |
Array
(
[id] => 8335073
[patent_doc_number] => 20120201779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'ANTIHISTAMINE AND ANTIHISTAMINE-LIKE NASAL APPLICATION, PRODUCTS'
[patent_app_type] => utility
[patent_app_number] => 13/446134
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3211
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13446134
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/446134 | ANTIHISTAMINE AND ANTIHISTAMINE-LIKE NASAL APPLICATION, PRODUCTS | Apr 12, 2012 | Abandoned |
Array
(
[id] => 8328264
[patent_doc_number] => 08236358
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2012-08-07
[patent_title] => 'Phosphate-binding magnesium salts and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/445771
[patent_app_country] => US
[patent_app_date] => 2012-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10590
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13445771
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/445771 | Phosphate-binding magnesium salts and uses thereof | Apr 11, 2012 | Issued |
Array
(
[id] => 8346903
[patent_doc_number] => 20120207828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'LARGE DOSE RIBAVIRIN FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/441560
[patent_app_country] => US
[patent_app_date] => 2012-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4033
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13441560
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/441560 | LARGE DOSE RIBAVIRIN FORMULATIONS | Apr 5, 2012 | Abandoned |
Array
(
[id] => 8708572
[patent_doc_number] => 20130065862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'FORMULATIONS AND USES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/439594
[patent_app_country] => US
[patent_app_date] => 2012-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14055
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13439594
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/439594 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives | Apr 3, 2012 | Issued |
Array
(
[id] => 8312679
[patent_doc_number] => 20120189704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'NOVEL INJECTABLE CHITOSAN MIXTURES FORMING HYDROGELS'
[patent_app_type] => utility
[patent_app_number] => 13/438542
[patent_app_country] => US
[patent_app_date] => 2012-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14181
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13438542
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/438542 | NOVEL INJECTABLE CHITOSAN MIXTURES FORMING HYDROGELS | Apr 2, 2012 | Abandoned |
Array
(
[id] => 8324356
[patent_doc_number] => 20120196766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'Therapeutic Use of Farnesyltransferase Inhibitors and Methods of Monitoring the Efficacy Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/431200
[patent_app_country] => US
[patent_app_date] => 2012-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 23423
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13431200
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/431200 | Therapeutic Use of Farnesyltransferase Inhibitors and Methods of Monitoring the Efficacy Thereof | Mar 26, 2012 | Abandoned |
Array
(
[id] => 8737790
[patent_doc_number] => 08409557
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-02
[patent_title] => 'Topical formulations for the prevention of sexually transmitted disease and methods of producing the same'
[patent_app_type] => utility
[patent_app_number] => 13/430267
[patent_app_country] => US
[patent_app_date] => 2012-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4281
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13430267
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/430267 | Topical formulations for the prevention of sexually transmitted disease and methods of producing the same | Mar 25, 2012 | Issued |
Array
(
[id] => 8290391
[patent_doc_number] => 20120178724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'Compositions for Reducing the Incidence of Drug Induced Arrhythmia'
[patent_app_type] => utility
[patent_app_number] => 13/427458
[patent_app_country] => US
[patent_app_date] => 2012-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2568
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13427458
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/427458 | Compositions for Reducing the Incidence of Drug Induced Arrhythmia | Mar 21, 2012 | Abandoned |
Array
(
[id] => 10940138
[patent_doc_number] => 20140343159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'FORMULATION OF SMALL ADRENERGIC AGONIST SALT FORMS IN ORGANIC SOLVENTS'
[patent_app_type] => utility
[patent_app_number] => 14/122442
[patent_app_country] => US
[patent_app_date] => 2012-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6153
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14122442
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/122442 | FORMULATION OF SMALL ADRENERGIC AGONIST SALT FORMS IN ORGANIC SOLVENTS | Mar 8, 2012 | Abandoned |
Array
(
[id] => 8277442
[patent_doc_number] => 20120171307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-05
[patent_title] => 'Magnesium Compositions and Uses Thereof for Neurological Disorders'
[patent_app_type] => utility
[patent_app_number] => 13/402648
[patent_app_country] => US
[patent_app_date] => 2012-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 37224
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13402648
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/402648 | Magnesium compositions and uses thereof for neurological disorders | Feb 21, 2012 | Issued |